نتائج البحث - "Chiari, Rita"

1

دورية أكاديمية

Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program

المساهمون: Passiglia, Francesco, Lucia Reale, Maria, Lo Russo, Giuseppe, Pasello, Giulia, Minuti, Gabriele, Bulotta, Alessandra, Galetta, Domenico, Pelizzari, Giacomo, Sini, Claudio, Bria, Emilio, Roca, Elisa, Pilotto, Sara, Genova, Carlo, Metro, Giulio, Citarella, Fabrizio, Chiari, Rita, Cortinovis, Diego, Delmonte, Angelo, Russo, Alessandro, Tiseo, Marcello, Cerea, Giulio, Carta, Annamaria, Scotti, Vieri, Vavalà, Tiziana, Brambilla, Marta, Buffoni, Lucio, Buosi, Roberta, Catania, Chiara, Gori, Stefania, Grisanti, Salvatore, Agustoni, Francesco, Garbo, Edoardo, Malapelle, Umberto, Novello, Silvia

مصطلحات موضوعية: KRASp.G12C, Non-small cell lung cancer, Sotorasib, Targeted therapy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38157806; volume:187; firstpage:107444; journal:LUNG CANCER; https://hdl.handle.net/11577/3503269Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85181527265

الإتاحة: https://doi.org/10.1016/j.lungcan.2023.107444Test
https://hdl.handle.net/11577/3503269Test

View record in BASE

2

دورية أكاديمية

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

المؤلفون: Massari, Francesco, Santoni, Matteo, Takeshita, Hideki, Okada, Yohei, Tapia, Jose Carlos, Basso, Umberto, Maruzzo, Marco, Scagliarini, Sarah, Büttner, Thomas, Fornarini, Giuseppe, Myint, Zin W., Galli, Luca, Souza, Vinicius Carrera, Pichler, Renate, De Giorgi, Ugo, Gandur, Nathalia, Lam, Elaine T., Gilbert, Danielle, Popovic, Lazar, Grande, Enrique, Mammone, Giulia, Berardi, Rossana, Crabb, Simon J., Kemp, Robert, Molina-Cerrillo, Javier, Freitas, Marcelo, Luz, Murilo, Iacovelli, Roberto, Calabrò, Fabio, Tural, Deniz, Atzori, Francesco, Küronya, Zsófia, Chiari, Rita, Campos, Saul, Caffo, Orazio, Fay, André P., Kucharz, Jakub, Zucali, Paolo Andrea, Rinck, José Augusto, Zeppellini, Annalisa, Bastos, Diogo Assed, Aurilio, Gaetano, Mota, Augusto, Trindade, Karine, Ortega, Cinzia, Sade, Juan Pablo, Rizzo, Mimma, Fiala, Ondřej, Vau, Nuno, Giannatempo, Patrizia

وصف الملف: text

العلاقة: https://eprints.soton.ac.uk/489845/1/s00262-024-03682-w.pdfTest; Massari, Francesco, Santoni, Matteo and Takeshita, Hideki , et al. (2024) Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study. Cancer immunology, immunotherapy : CII, 73 (6), [106]. (doi:10.1007/s00262-024-03682-w ).

الإتاحة: https://doi.org/10.1007/s00262-024-03682-wTest
https://eprints.soton.ac.uk/489845Test/
https://eprints.soton.ac.uk/489845/1/s00262-024-03682-w.pdfTest

View record in BASE

3

دورية أكاديمية

Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer

المؤلفون: Chen, Joseph, bearz, alessandra, Kim, Dong-Wan, Mamdani, Hirva, Bauman, J. R., chiari, rita, FELIP, ENRIQUETA

المساهمون: Institut Català de la Salut, Chen J Pfzer, New York, NY, USA. Genentech, South San Francisco, CA, USA. Bearz A National Cancer Institute, Aviano, Italy. Kim DW Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea. Mamdani H Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. Bauman J Fox Chase Cancer Center, Philadelphia, PA, USA. Chiari R Medical Oncology, AULSS6 Veneto, Padua, Italy. Felip E Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Proteïnes quinases - Inhibidors - Ús terapèutic, Pulmons - Càncer - Tractament, Glicoproteïnes, DISEASES::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Glycoproteins, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::glicoproteínas, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas

وصف الملف: application/pdf

العلاقة: Clinical Pharmacokinetics;63; https://doi.org/10.1007/s40262-023-01309-4Test; Chen J, Bearz A, Dong-Wan K, Mamdani H, Bauman J, Chiari R, et al. Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer. Clin Pharmacokinet. 2024 Feb;63:171–182.; https://hdl.handle.net/11351/11032Test; 001121084900001

الإتاحة: https://doi.org/10.1007/s40262-023-01309-4Test
https://hdl.handle.net/11351/11032Test

View record in BASE

4

دورية أكاديمية

Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study

المؤلفون: Yang, James Chih-Hsin, Reckamp, Karen L, Kim, Young-Chul, Novello, Silvia, Smit, Egbert F, Lee, Jong-Seok, Su, Wu-Chou, Akerley, Wallace L, Blakely, Collin M, Groen, Harry JM, Bazhenova, Lyudmila, Costa, Enric Carcereny, Chiari, Rita, Hsia, Te-Chun, Golsorkhi, Tony, Despain, Darrin, Shih, Danny, Popat, Sanjay, Wakelee, Heather

المصدر: JTO Clinical and Research Reports. 2(2)

مصطلحات موضوعية: Cancer, Clinical Research, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, EGFR tyrosine kinase inhibitor, Epidermal growth factor receptor mutations, Non–small cell lung cancer, Phase III randomized clinical trial, Rociletinib

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/30c390kwTest

View record in eScholarship

5

دورية أكاديمية

Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer

المؤلفون: Chen, Joseph, Bearz, Alessandra, Kim, Dong-Wan, Mamdani, Hirva, Bauman, Jessica, Chiari, Rita, Ou, Sai-Hong Ignatius, Solomon, Benjamin J., Soo, Ross A., Felip, Enriqueta, Shaw, Alice T., Thurm, Holger, Clancy, Jill S., Lee, Kimberly, O’Gorman, Melissa, Tanski, Cherie, Pithavala, Yazdi K.

المساهمون: Pfizer

المصدر: Clinical Pharmacokinetics ; volume 63, issue 2, page 171-182 ; ISSN 0312-5963 1179-1926

مصطلحات موضوعية: Pharmacology (medical), Pharmacology

الإتاحة: https://doi.org/10.1007/s40262-023-01309-4Test

View record in BASE

6

دورية أكاديمية

KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab

المؤلفون: Chiari, Rita, Palladino, Silvia, Emili, Rita, De Lisa, Mariagrazia, Sarti, Donatella, Catalano, Vincenzo, Magnani, Mauro, Graziano, Francesco, Ruzzo, Annamaria

المصدر: Scientific Reports ; volume 13, issue 1 ; ISSN 2045-2322

مصطلحات موضوعية: Multidisciplinary

الإتاحة: https://doi.org/10.1038/s41598-023-48304-0Test
https://www.nature.com/articles/s41598-023-48304-0.pdfTest
https://www.nature.com/articles/s41598-023-48304-0Test

View record in BASE

7

دورية أكاديمية

Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)

المصدر: Scientific Reports ; volume 13, issue 1 ; ISSN 2045-2322

مصطلحات موضوعية: Multidisciplinary

الإتاحة: https://doi.org/10.1038/s41598-023-28464-9Test
https://www.nature.com/articles/s41598-023-28464-9.pdfTest
https://www.nature.com/articles/s41598-023-28464-9Test

View record in BASE

8

دورية أكاديمية

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

المؤلفون: Santoni, Matteo, Buti, Sebastiano, Myint, Zin W., Maruzzo, Marco, Iacovelli, Roberto, Pichler, Martin, Kopecky, Jindrich, Kucharz, Jakub, Rizzo, Mimma, Galli, Luca, Büttner, Thomas, De Giorgi, Ugo, Kanesvaran, Ravindran, Fiala, Ondřej, Grande, Enrique, Zucali, Paolo Andrea, Kopp, Ray Manneh, Fornarini, Giuseppe, Bourlon, Maria T., Scagliarini, Sarah, Molina-Cerrillo, Javier, Aurilio, Gaetano, Matrana, Marc R., Pichler, Renate, Cattrini, Carlo, Büchler, Tomas, Massari, Francesco, Seront, Emmanuel, Calabrò, Fabio, Pinto, Alvaro, Berardi, Rossana, Zgura, Anca, Mammone, Giulia, Ansari, Jawaher, Atzori, Francesco, Chiari, Rita, Bamias, Aristotelis, Caffo, Orazio, Procopio, Giuseppe, Sunela, Kaisa, Bassanelli, Maria, Ortega, Cinzia, Grillone, Francesco, Landmesser, Johannes, Milella, Michele, Messina, Carlo, Küronya, Zsófia, Mosca, Alessandra, Bhuva, Dipen, Santini, Daniele, Vau, Nuno, Morelli, Franco, Incorvaia, Lorena, Rebuzzi, Sara Elena, Roviello, Giandomenico, Soares, Andrey, Bisonni, Renato, Bimbatti, Davide, Zabalza, Ignacio Ortego, Rizzo, Alessandro, Mollica, Veronica, Sorgentoni, Giulia, Monteiro, Fernando Sabino M., Battelli, Nicola, Bracarda, Sergio, Porta, Camillo

المساهمون: Santoni, Matteo, Buti, Sebastiano, Myint, Zin W., Maruzzo, Marco, Iacovelli, Roberto, Pichler, Martin, Kopecky, Jindrich, Kucharz, Jakub, Rizzo, Mimma, Galli, Luca, Büttner, Thoma, De Giorgi, Ugo, Kanesvaran, Ravindran, Fiala, Ondřej, Grande, Enrique, Zucali, Paolo Andrea, Kopp, Ray Manneh, Fornarini, Giuseppe, Bourlon, Maria T., Scagliarini, Sarah, Molina-Cerrillo, Javier, Aurilio, Gaetano, Matrana, Marc R., Pichler, Renate, Cattrini, Carlo, Büchler, Toma, Massari, Francesco, Seront, Emmanuel, Calabrò, Fabio, Pinto, Alvaro, Berardi, Rossana, Zgura, Anca, Mammone, Giulia, Ansari, Jawaher, Atzori, Francesco, Chiari, Rita, Bamias, Aristoteli, Caffo, Orazio, Procopio, Giuseppe, Sunela, Kaisa, Bassanelli, Maria, Ortega, Cinzia, Grillone, Francesco, Landmesser, Johanne, Milella, Michele, Messina, Carlo, Küronya, Zsófia, Mosca, Alessandra, Bhuva, Dipen, Santini, Daniele, Vau, Nuno, Morelli, Franco, Incorvaia, Lorena, Rebuzzi, Sara Elena, Roviello, Giandomenico, Soares, Andrey, Bisonni, Renato, Bimbatti, Davide, Zabalza, Ignacio Ortego, Rizzo, Alessandro, Mollica, Veronica, Sorgentoni, Giulia, Monteiro, Fernando Sabino M., Battelli, Nicola, Bracarda, Sergio, Porta, Camillo

مصطلحات موضوعية: ARON-1 study, Immune-oncology combination, Immunotherapy, Intermediate-risk International Metastatic Renal Cell Carcinoma Database Consortium criteria, NCT05287464, Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium criteria, Renal cell carcinoma, Survival

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37481365; info:eu-repo/semantics/altIdentifier/wos/WOS:001171176000001; volume:7; issue:1; firstpage:102; lastpage:111; numberofpages:10; journal:EUROPEAN UROLOGY ONCOLOGY; https://hdl.handle.net/11573/1705093Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85184074251

الإتاحة: https://doi.org/10.1016/j.euo.2023.07.003Test
https://hdl.handle.net/11573/1705093Test

View record in BASE

9

دورية أكاديمية

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status

المؤلفون: Cortellini, Alessio, Giusti, Raffaele, Filetti, Marco, Citarella, Fabrizio, Adamo, Vincenzo, Santini, Daniele, Buti, Sebastiano, Nigro, Olga, Cantini, Luca, Di Maio, Massimo, Aerts, Joachim G J V, Bria, Emilio, Bertolini, Federica, Ferrara, Miriam Grazia, Ghidini, Michele, Grossi, Francesco, Guida, Annalisa, Berardi, Rossana, Morabito, Alessandro, Genova, Carlo, Mazzoni, Francesca, Antonuzzo, Lorenzo, Gelibter, Alain, Marchetti, Paolo, Chiari, Rita, Macerelli, Marianna, Rastelli, Francesca, Della Gravara, Luigi, Gori, Stefania, Tuzi, Alessandro, De Tursi, Michele, Di Marino, Pietro, Mansueto, Giovanni, Pecci, Federica, Zoratto, Federica, Ricciardi, Serena, Migliorino, Maria Rita, Passiglia, Francesco, Metro, Giulio, Spinelli, Gian Paolo, Banna, Giuseppe L, Friedlaender, Alex, Addeo, Alfredo, Ficorella, Corrado, Porzio, Giampiero, Tiseo, Marcello, Russano, Marco, Russo, Alessandro, Pinato, David James

المساهمون: Cortellini, Alessio, Giusti, Raffaele, Filetti, Marco, Citarella, Fabrizio, Adamo, Vincenzo, Santini, Daniele, Buti, Sebastiano, Nigro, Olga, Cantini, Luca, Di Maio, Massimo, Aerts, Joachim G J V, Bria, Emilio, Bertolini, Federica, Ferrara, Miriam Grazia, Ghidini, Michele, Grossi, Francesco, Guida, Annalisa, Berardi, Rossana, Morabito, Alessandro, Genova, Carlo, Mazzoni, Francesca, Antonuzzo, Lorenzo, Gelibter, Alain, Marchetti, Paolo, Chiari, Rita, Macerelli, Marianna, Rastelli, Francesca, Della Gravara, Luigi, Gori, Stefania, Tuzi, Alessandro, De Tursi, Michele, Di Marino, Pietro, Mansueto, Giovanni, Pecci, Federica, Zoratto, Federica, Ricciardi, Serena, Migliorino, Maria Rita, Passiglia, Francesco, Metro, Giulio, Spinelli, Gian Paolo, Banna, Giuseppe L, Friedlaender, Alex, Addeo, Alfredo, Ficorella, Corrado, Porzio, Giampiero, Tiseo, Marcello, Russano, Marco, Russo, Alessandro, Pinato, David James

مصطلحات موضوعية: DDR gene, Family history of cancer, Immune checkpoint inhibitor, Immunotherapy, NSCLC, Pembrolizumab, Carcinoma, Non-Small-Cell Lung, DNA Damage, Female, Human, Lung Neoplasm, Male, Treatment Outcome

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35062993; info:eu-repo/semantics/altIdentifier/wos/WOS:000745488900001; volume:15; issue:1; firstpage:1; lastpage:6; numberofpages:6; journal:JOURNAL OF HEMATOLOGY & ONCOLOGY; https://hdl.handle.net/11383/2142213Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123438477

الإتاحة: https://doi.org/10.1186/s13045-022-01226-2Test
https://hdl.handle.net/11383/2142213Test

View record in BASE

10

دورية أكاديمية

Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy

المساهمون: Banna, Giuseppe L., Tiseo, Marcello, Cortinovis, Diego L., Facchinetti, Francesco, Aerts, Joachim G. J. V., Baldessari, Cinzia, Giusti, Raffaele, Bria, Emilio, Grossi, Francesco, Berardi, Rossana, Morabito, Alessandro, Catino, Annamaria, Genova, Carlo, Mazzoni, Francesca, Gelibter, Alain, Rastelli, Francesca, Macerelli, Marianna, Chiari, Rita, Gori, Stefania, Mansueto, Giovanni, Citarella, Fabrizio, Cantini, Luca, Rijavec, Erika, Bertolini, Federica, Cappuzzo, Federico, De Toma, Alessandro, Friedlaender, Alex, Metro, Giulio, Pensieri, Maria Vittoria, Porzio, Giampiero, Ficorella, Corrado, Pinato, David J., Cortellini, Alessio, Addeo, Alfredo

مصطلحات موضوعية: immunotherapy, inflammation, neutrophil-to-lymphocyte ratio (NLR), non-small cell lung cancer, performance status

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34939342; info:eu-repo/semantics/altIdentifier/wos/WOS:000733356800001; volume:13; issue:3; firstpage:483; lastpage:488; numberofpages:6; journal:THORACIC CANCER; https://hdl.handle.net/11585/964135Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85121523648

الإتاحة: https://doi.org/10.1111/1759-7714.14256Test
https://hdl.handle.net/11585/964135Test

View record in BASE

تنقيح النتائج